 |
|
|
| |
Prevention of Liver-Related Complications in Patients With Chronic Hepatitis C Receiving Elbasvir/Grazoprevir Compared With Pegylated Interferon/Ribavirin andNo Treatment in Vietnam
|
| |
| |
Reported by Jules Levin
APASL 2017 Feb 15-19 Shanghai, China
Shelby Corman, PharmD, MS, BCPS1; Elamin H. Elbasha, PhD2;Thuy Thi Thu Nguyen, PhD, MBA3; Quang Khac Luong Nguyen MD, PhD4; Chizoba Nwankwo, PhD2
1Pharmerit International, Bethesda, MD, USA
2Merck & Co., Inc., Kenilworth, NJ, USA
3University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam
4Merck Sharp & Dohme, Ho Chi Minh City, Vietnam
|
| |
|
|
|
|
|
